Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma <i>In vitro</i> and <i>In vivo</i>
Nobuyuki Watanabe(Nagoya City University), Yoshio Naomoto(Kawasaki Medical School)
Cited by 52
Related Papers
Inhibition of the Growth Factor MDK/Midkine by a Novel Small Molecule Compound to Treat Non-Small Cell Lung Cancer
|PLoS ONE|2013|74
Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
|Molecular Cancer Therapeutics|2009|68
SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma
|Scientific Reports|2016|56